ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.
Neru Health, an artificial intelligence (AI)-powered care automation platform for sleep clinics and durable medical equipment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback